
Nashville Capital Network
Description
Nashville Capital Network (NCN) is a prominent for-profit limited partnership established in 2003, dedicated to providing equity capital to early-stage companies. Based in Nashville, Tennessee, NCN primarily focuses its investments on the healthcare and technology sectors, with a strong geographic emphasis on the Southeast United States. Its strategic approach aims to foster growth within these critical industries by supporting innovative startups.
NCN operates by managing a series of angel funds, having successfully raised capital across eight distinct funds since its inception. Collectively, these funds have amassed over $60 million in committed capital, demonstrating a consistent ability to attract investor interest. Their most recent fund, NCN Angel Fund VIII, closed in 2022 with $15 million, underscoring their ongoing commitment to new investments.
The firm's investment strategy typically involves initial checks ranging from $250,000 to $1,000,000, targeting companies poised for significant growth. To date, Nashville Capital Network has invested in over 70 companies, building a diverse portfolio across its core sectors. Beyond initial funding, NCN plays an active role in supporting its portfolio companies, having facilitated over $1.5 billion in follow-on capital, which significantly aids in their long-term development and expansion.
Investor Profile
Nashville Capital Network has backed more than 58 startups, with 1 new investments in the last 12 months alone. The firm has led 12 rounds, about 21% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Health Care, Medical, Software.
- Typical check size: $250K – $1M.
Stage Focus
- Series A (29%)
- Seed (17%)
- Series Unknown (17%)
- Series B (16%)
- Series C (14%)
- Private Equity (3%)
- Pre Seed (2%)
- Series D (2%)
Country Focus
- United States (95%)
- Canada (3%)
Industry Focus
- Health Care
- Medical
- Software
- Biotechnology
- Enterprise Software
- Health Diagnostics
- Analytics
- Pharmaceutical
- Advertising
- Consulting
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.